Shabbir Ahmed Ansari, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thromboplastin | 5 | 2020 | 286 | 1.750 |
Why?
|
| Cell-Derived Microparticles | 2 | 2020 | 161 | 0.790 |
Why?
|
| Aldehydes | 1 | 2020 | 171 | 0.680 |
Why?
|
| Membrane Lipids | 1 | 2019 | 251 | 0.600 |
Why?
|
| Sulfhydryl Compounds | 1 | 2019 | 300 | 0.580 |
Why?
|
| Disulfides | 1 | 2019 | 464 | 0.560 |
Why?
|
| Coagulants | 1 | 2016 | 46 | 0.540 |
Why?
|
| Phosphatidylserines | 1 | 2016 | 188 | 0.490 |
Why?
|
| Factor VIIa | 3 | 2021 | 102 | 0.460 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 451 | 0.460 |
Why?
|
| Oxidative Stress | 2 | 2020 | 3062 | 0.350 |
Why?
|
| Thrombosis | 2 | 2020 | 3028 | 0.330 |
Why?
|
| Blood Coagulation | 3 | 2020 | 1154 | 0.330 |
Why?
|
| Hemostasis | 2 | 2021 | 466 | 0.290 |
Why?
|
| Cell Membrane | 1 | 2016 | 3686 | 0.280 |
Why?
|
| Receptor, PAR-2 | 3 | 2019 | 33 | 0.230 |
Why?
|
| Inflammation | 2 | 2020 | 10717 | 0.220 |
Why?
|
| Receptor, PAR-1 | 1 | 2021 | 113 | 0.180 |
Why?
|
| Protein Disulfide Reductase (Glutathione) | 1 | 2019 | 7 | 0.170 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2018 | 112 | 0.150 |
Why?
|
| Thrombin | 1 | 2020 | 592 | 0.150 |
Why?
|
| Factor VIIIa | 1 | 2017 | 16 | 0.150 |
Why?
|
| Trypsin | 1 | 2018 | 495 | 0.150 |
Why?
|
| Autocrine Communication | 1 | 2018 | 169 | 0.150 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2019 | 200 | 0.140 |
Why?
|
| Factor X | 1 | 2016 | 64 | 0.140 |
Why?
|
| Flavonoids | 1 | 2019 | 445 | 0.130 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2018 | 462 | 0.130 |
Why?
|
| Cricetulus | 1 | 2016 | 816 | 0.120 |
Why?
|
| Genomic Instability | 1 | 2018 | 693 | 0.120 |
Why?
|
| CHO Cells | 1 | 2016 | 1389 | 0.110 |
Why?
|
| Recombinant Proteins | 3 | 2021 | 6529 | 0.110 |
Why?
|
| Actins | 1 | 2020 | 2055 | 0.110 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 2001 | 0.100 |
Why?
|
| Phospholipids | 1 | 2016 | 787 | 0.100 |
Why?
|
| Mutagenesis | 1 | 2016 | 1229 | 0.100 |
Why?
|
| beta Catenin | 1 | 2017 | 1043 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2018 | 2455 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 1874 | 0.100 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 3087 | 0.090 |
Why?
|
| Enzyme Activation | 1 | 2016 | 3600 | 0.090 |
Why?
|
| Amino Acids | 1 | 2016 | 1715 | 0.090 |
Why?
|
| Antigens, CD | 1 | 2020 | 3910 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2021 | 4423 | 0.080 |
Why?
|
| Signal Transduction | 4 | 2019 | 23279 | 0.080 |
Why?
|
| Binding Sites | 1 | 2016 | 6046 | 0.070 |
Why?
|
| Monocytes | 1 | 2016 | 2562 | 0.070 |
Why?
|
| Animals | 6 | 2021 | 167153 | 0.070 |
Why?
|
| Cytokines | 1 | 2020 | 7263 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3720 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2020 | 18941 | 0.060 |
Why?
|
| Protein Binding | 1 | 2016 | 9309 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2019 | 3779 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 21793 | 0.050 |
Why?
|
| Cell Line | 1 | 2016 | 15646 | 0.050 |
Why?
|
| Cell Movement | 3 | 2019 | 5184 | 0.050 |
Why?
|
| Disease Progression | 1 | 2018 | 13429 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 11898 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 20890 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2018 | 3605 | 0.040 |
Why?
|
| Vimentin | 1 | 2019 | 255 | 0.040 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2018 | 67 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 16795 | 0.040 |
Why?
|
| Mice | 2 | 2021 | 80750 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2021 | 1735 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2017 | 124 | 0.030 |
Why?
|
| Humans | 9 | 2021 | 755562 | 0.030 |
Why?
|
| Cadherins | 1 | 2019 | 903 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 727 | 0.030 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2018 | 593 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 1116 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 15653 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2017 | 1532 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 8439 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2021 | 2563 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2017 | 1187 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 2107 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2018 | 2481 | 0.020 |
Why?
|
| Neoplasms | 1 | 2018 | 21887 | 0.020 |
Why?
|
| DNA Repair | 1 | 2018 | 2022 | 0.020 |
Why?
|
| Female | 4 | 2020 | 387930 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 2868 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2019 | 2500 | 0.020 |
Why?
|
| RNA Interference | 1 | 2017 | 2842 | 0.020 |
Why?
|
| DNA Damage | 1 | 2018 | 2413 | 0.020 |
Why?
|
| Breast | 1 | 2017 | 1977 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2868 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 3728 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14329 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 3606 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10394 | 0.010 |
Why?
|
| Male | 1 | 2020 | 356589 | 0.010 |
Why?
|
| Models, Biological | 1 | 2018 | 9452 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 218062 | 0.000 |
Why?
|
| Adult | 1 | 2019 | 217991 | 0.000 |
Why?
|